Brief: Reviva Announces Grant Of European Patent Covering Use Of Brilaroxazine For The Treatment Of Pulmonary Hypertension

Reviva Pharmaceuticals Holdings

09/07/2024 13:18

July 9 (Reuters) - Reviva Pharmaceuticals Holdings, Inc.
 RVPH.O :
    * REVIVA ANNOUNCES GRANT OF EUROPEAN PATENT COVERING USE OF
BRILAROXAZINE FOR THE TREATMENT OF PULMONARY HYPERTENSION
    * REVIVA ANNOUNCES GRANT OF EUROPEAN PATENT COVERING USE OF
BRILAROXAZINE FOR THE TREATMENT OF PULMONARY HYPERTENSION

Source text for Eikon:  ID:nGNX9lMRfP 
Further company coverage:  RVPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))